Ganoderma helps to reduce blood sugar
Can Herbs for Diabetes help to reduce blood sugar?
The root of most diseases
Diabetes happens when blood sugar level constantly stays at a higher level. This leads to many other diseases such as:
high blood pressure
and even impotence
Conventional treatment for diabetes uses drug medications to suppress blood sugar level. Before taking any herbs for diabetes, you too must begin your treatment with medication.
There are 2 groups of diabetes medication. The first type mainly forces the already weakened pancreas to produce more insulin hormone to reduce blood sugar level.
The recommended treatment for diabetes is to combine western medication with herbs for diabetes prescribed according to Traditional Chinese Medicine (TCM).
Middle part heat (stomach)
Lower part heat (kidney)
According to each specific condition, TCM doctor will prescribe the suitable herbs for diabetes to improve the actual cause of this disease. In the above 3 conditions, the main required healing functions are to:
2) Enhance kidney energy
3) Enhance “yin” energy
4) Enhance body energy
5) Improve blood circulation
With these healing principles, the first recommended herbs for diabetes are Five Leaves Ginseng herb (Rhinacanthus Nasutus) and White Crane Lingzhi herb (Gynostemma Pentaphyllum).
The fourth herb is Ganoderma Lucidum. This herb helps to boost body energy and improve blood circulation. Therefore, Ganoderma Lucidum is one of the important herbs for diabetes.
Before this, please take note of the following:
2) Don’t get angry and stressful
3) Exercise regularly
Subscription Options Purchase Options Submission « Previous article | Next article »
Home / Volume 6, 2004 Issue 1 / Article
Institute of Food, Nutrition and Human Health, Massey University; Landcare Research, Private Bag 92170, Auckland, New Zealand
Institute of Human Nutrition and Department of Biochemistry, Qingdao Medical College, Qingdao University, China
Department of Internal Medicine, Fuzhou General Hospital of Nanjing Military Region of the Peoples’ Liberation Army, Fuzhou, R.P. China
Department of Integrated Medicine. Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, R.P. China
Division of Pharmacy, School of Life Sciences, Faculty of Science, Queensland University of Technology, Queensland 4001, Australia; and Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore
Animal studies have demonstrated that the polysaccharide fractions of Ganoderma lucidum (Ling Zhi, reishi mushroom) have potential hypoglycemic and hypolipidemic activities. This clinical study aimed to evaluate the efficacy and safety of Ganopoly (polysaccharide fractions extracted from G. lucidum by patented technique) in 71 patients with confirmed type II diabetes mellitus (DM). Eligibility criteria included type II DM of >3 months’ duration for which patients were not receiving insulin; age >18 years; normal vital signs for age and disease state; normal electrocardiogram (ECG); and fasting plasma glucose (FPG) level of 18.104.22.168 mmol/L in sulfonylurea-naive patients or an FPG <10 mmol/L before washout in sulfonylurea-treated patients. Patients were randomly grouped to be given either Ganopoly or placebo orally at 1800 mg three times daily for 12 weeks. Patients underwent 4 weeks of dose adjustment followed by 8 weeks of dose maintenance. Fasting and stimulated glycosylated hemoglobin (HbA1c), plasma glucose, insulin, and C-peptide were monitered at predetermined intervals. Adverse events and hypoglycemic episodes were recorded. The treatment of Ganopoly significantly decreased the mean HbA1c from 8.4 at baseline to 7.6% at 12 weeks. Significant changes in mean FPG and PPG levels at the last visit paralleled the changes in mean HbA1c levels. At baseline, the mean FPG and PPG values in patients treated with Ganopoly were 12.0 and 13.6 mmol/L, respectively. At week 12, mean PPG values had decreased to 11.8 mmol/L. However, these parameters did not change or slightly increased in patients receiving placebo. The between-group difference in PPG levels at week 12 was significant (p < 0.05). Changes in fasting insulin, 2-hour post-prandial insulin, fasting C-peptide, and 2-hour post-prandial C-peptide were consistent, with the between-group differences in these end points being significant at the last visit. Overall, Ganopoly was well tolerated. This study demonstrated that Ganopoly was efficacious and safe in lowering blood glucose concentrations.
Chinese herb Ganoderma lucidum mushroom can cure diabetes
A team from the University of Western Sydney’s Centre for Complementary Medicine Research (CompleMED) is working with the Cardiac Health Institute to find out if the medicinal mushroom, Ganoderma lucidum, can reduce high blood sugar, often a precursor to diabetes – as well as treat other health problems.
The clinical trial is the first of its kind to rigorously test the mushroom – known in Asia as the ‘King of herbs’, because of its huge range of medicinal properties – and needs 170 Sydneysiders to take part.